Results 221 to 230 of about 16,590,594 (260)

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

Transplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia, Britta L. Hirsch, Irene A. Abela, Karen E. Doucette   +3 more
wiley   +1 more source

Red Alga Porphyridium Supports High-Yield Production of a Functional Chimeric Hepatitis B Surface Antigen With Strong Cellular and Humoral Immunogenicity. [PDF]

Plant Biotechnol J
Pantazica AM, Hammel A, Caras I, Ionescu I, Tucureanu C, Onu A, Murace M, Liu Clarke J, Stavaru C, Branza-Nichita N, Bock R.   +10 more
europepmc   +1 more source

Integrated Screening for Communicable and Non‐Communicable Diseases Multimorbidity in Low‐ and Middle‐Income Countries: A Scoping Review

Tropical Medicine &International Health, EarlyView.
ABSTRACT Multimorbidity is a growing public health challenge in low‐ and middle‐income countries (LMICs), where resource‐limited and fragmented health systems impede coordinated disease detection and management. Integrated screening offers a promising strategy to improve early detection of communicable and non‐communicable diseases.
Evans Duah, Nyeleti Chauke, Smangaliso Morerwa, Kuhlula Maluleke, Gabrielle Thompson, George Obeng Adjei, Paramjit Gill, Tivani Mashamba‐Thompson   +7 more
wiley   +1 more source

Immunological characterization of hepatitis B core antigen antibody among vaccinated adults lacking hepatitis B surface antigen in ethiopia: A multicenter facility-based study. [PDF]

Sci Rep
Adugna A, Abebaw D, Teffera ZH, Kindie Y, Belay WY, Mihiret GT, Kassaw AB, Abera MB, Abebe G, Alem A, Geto Z, Seid MA, Yesuf HA, Asfaw MS, Jemal M.   +14 more
europepmc   +1 more source

Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation

Transfusion, EarlyView.
Abstract Background Newly positive hepatitis B virus (HBV) serologic results after allogeneic hematopoietic cell transplantation (HCT) may reflect passive antibody transfer from blood‐derived products rather than HBV infection. We investigated the incidence and temporal patterns of hepatitis B surface antibody (anti‐HBs) and antibody to hepatitis B ...
Takaaki Konuma, Maki Monna‐Oiwa, Etsuko Nagai, Seiko Kato, Shohei Andoh, Junichi Kuroda, Satoshi Takahashi, Yasuhito Nannya   +7 more
wiley   +1 more source

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention. [PDF]

Pathogens
Huang SW, Long H, Huang JQ.
europepmc   +1 more source

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus. [PDF]

Hum Vaccin Immunother
Ding L, Huang J, Huang S.
europepmc   +1 more source

Dynamic predicting hepatitis B surface antigen decline rate during treatment for patients with chronic hepatitis B. [PDF]

Infect Dis Model
Xin Y, Wang Y, Li Q, Zhang X, Wang K, Huang G.   +5 more
europepmc   +1 more source

Persistent Immune Thrombocytopenia as a Post‐Acute Sequelae of COVID‐19: A Case Report

Public Health Challenges, Volume 5, Issue 4, December 2026.
ABSTRACT Immune thrombocytopenia (ITP) is a recognized hematologic complication associated with coronavirus disease 2019 (COVID‐19), but its persistence years after acute infection remains uncommon. We present a case of a 52‐year‐old male who was diagnosed with COVID‐19 in June 2020. Following recovery from the acute illness, he had persistent fatigue,
Riazullah, Hakim Ullah Wazir, Aafeen Mujeeb, Hamid Ahmad, Hameed Ur Rehman, Inibehe Ime Okon   +5 more
wiley   +1 more source

Association of alanine aminotransferase flares with hepatitis B surface antigen loss and clinical outcomes in treated and untreated patients with chronic hepatitis B virus infection: A US retrospective cohort study. [PDF]

Ther Adv Infect Dis
Drysdale M, Morais E, Chang R, Wang S, Pinaire M, Mohan M, Song R, Duh MS, Dolman G, Theodore D, Gillespie IA.   +10 more
europepmc   +1 more source